BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33813379)

  • 21. Two cases of AML (M2) with a t(8;19)(q22;q13): a new cytogenetic variant.
    Xue Y; Niu C; Chen S; Wang Y; Guo Y; Xie X; Lu D; Li P
    Cancer Genet Cytogenet; 2000 Apr; 118(2):154-8. PubMed ID: 10748298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy.
    Ananthaneni A; Benzar T; Hafiz N; Akabane H
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36977512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
    Schmidt HH; Strehl S; Thaler D; Strunk D; Sill H; Linkesch W; Jäger U; Sperr W; Greinix HT; König M; Emberger W; Haas OA
    Leukemia; 2004 Jun; 18(6):1115-21. PubMed ID: 15085163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias.
    Murati A; Adélaïde J; Quilichini B; Rémy V; Sainty D; Stoppa AM; Bernard P; Olschwang S; Birnbaum D; Chaffanet M; Mozziconacci MJ
    Haematologica; 2007 Feb; 92(2):262-3. PubMed ID: 17296583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in acute myeloid leukemia with t(10;11)(p11.2;q23).
    Taki T; Shibuya N; Taniwaki M; Hanada R; Morishita K; Bessho F; Yanagisawa M; Hayashi Y
    Blood; 1998 Aug; 92(4):1125-30. PubMed ID: 9694699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
    Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
    Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute myeloid leukemia with t(11;12)(p15;q13) translocation: two cases report and literature review].
    Gong BF; Li QH; Li W; Wang Y; Wei H; Wang JY; Zhao XL; Lin D; Li CW; Liu XP; Mi YC; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):830-3. PubMed ID: 24171954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid Leukemia.
    Capela de Matos RR; Ney Garcia DR; Othman MAK; Moura Ferreira G; Melo JB; Carreira IM; Meyer C; Marschalek R; Costa ES; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Cytogenet Genome Res; 2019; 157(4):213-219. PubMed ID: 30974445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.
    Aguiar RC; Chase A; Coulthard S; Macdonald DH; Carapeti M; Reiter A; Sohal J; Lennard A; Goldman JM; Cross NC
    Blood; 1997 Oct; 90(8):3130-5. PubMed ID: 9376594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute myeloid leukemia M2and t (8; 19) (q22; q13)].
    Li P; Guo Y; Xie X; Wang Y; Lu D; Xue Y
    Zhonghua Xue Ye Xue Za Zhi; 2000 Feb; 21(2):84-6. PubMed ID: 11876965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-terminal BRE overexpression in 11q23-rearranged and t(8;16) acute myeloid leukemia is caused by intragenic transcription initiation.
    Marneth AE; Prange KHM; Al Hinai ASA; Bergevoet SM; Tesi N; Janssen-Megens EM; Kim B; Sharifi N; Yaspo ML; Kuster J; Sanders MA; Stoetman ECG; Knijnenburg J; Arentsen-Peters TCJM; Zwaan CM; Stunnenberg HG; van den Heuvel-Eibrink MM; Haferlach T; Fornerod M; Jansen JH; Valk PJM; van der Reijden BA; Martens JHA
    Leukemia; 2018 Mar; 32(3):828-836. PubMed ID: 28871137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translocation (8;12)(q13;p13) during disease progression in acute myelomonocytic leukemia with t(11;19)(q23;p13.1).
    Yamamoto K; Nagata K; Tsurukubo Y; Inagaki K; Ono R; Taki T; Hayashi Y; Hamaguchi H
    Cancer Genet Cytogenet; 2002 Aug; 137(1):64-7. PubMed ID: 12377416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.
    Turner-Ivey B; Guest ST; Irish JC; Kappler CS; Garrett-Mayer E; Wilson RC; Ethier SP
    Neoplasia; 2014 Aug; 16(8):644-55. PubMed ID: 25220592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KAT6A and ENL Form an Epigenetic Transcriptional Control Module to Drive Critical Leukemogenic Gene-Expression Programs.
    Yan F; Li J; Milosevic J; Petroni R; Liu S; Shi Z; Yuan S; Reynaga JM; Qi Y; Rico J; Yu S; Liu Y; Rokudai S; Palmisiano N; Meyer SE; Sung PJ; Wan L; Lan F; Garcia BA; Stanger BZ; Sykes DB; Blanco MA
    Cancer Discov; 2022 Mar; 12(3):792-811. PubMed ID: 34853079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
    Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
    Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Myeloid Leukemia in an Infant with t(8;19)(p11.2;q13) Translocation: Case Report and a Review of the Literature.
    Eason AC; Bunting ST; Peterson JF; Saxe D; Sabnis HS
    Case Rep Hematol; 2019; 2019():4198415. PubMed ID: 31583141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].
    Chang WR; Park IJ; Lee HW; Park JS; Kim HC; Kim HJ; Han JH; Cho SR
    Korean J Lab Med; 2009 Oct; 29(5):390-5. PubMed ID: 19893346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complex t(8;14;21)(q22;q13;q22), a variant of t(8;21), with t(15;21)(q15;p11) in a patient with acute myelogenous leukemia (M1).
    Takahashi T; Maruyama Y; Satoh Y; Yoshimoto M; Tsujisaki M
    Cancer Genet Cytogenet; 2004 Dec; 155(2):152-3. PubMed ID: 15571802
    [No Abstract]   [Full Text] [Related]  

  • 39. A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)--case report and review of the literature.
    Stark B; Resnitzky P; Jeison M; Luria D; Blau O; Avigad S; Shaft D; Kodman Y; Gobuzov R; Ash S
    Leuk Res; 1995 Jun; 19(6):367-79. PubMed ID: 7596149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).
    Panagopoulos I; Isaksson M; Lindvall C; Hagemeijer A; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2003 Jan; 36(1):90-8. PubMed ID: 12461753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.